Volume 20 Issue 4
Apr.  2022
Turn off MathJax
Article Contents

doi: 10.16766/j.cnki.issn.1674-4152.002438
  • Received Date: 2021-03-11
    Available Online: 2022-08-20
  • loading
  • [1]
    POSFAI E, MARTON I, BORBENYI Z, et al. Myocardial infarction as a thrombotic complication of essential thrombocythemia and polycythemia vera[J]. Anatol J Cardiol, 2016, 16(6): 397-402.
    [2]
    LUBBERICH R K, WALENDA T, GOECKE T W, et al. Serum of myeloproliferative neoplasms stimulates hematopoietic stem and progenitor cells[J]. PLoS One, 2018, 13(5): 1-12.
    [3]
    王晓培, 程家凤, 郑茜茜. JAK2V617F突变阳性骨髓增殖性肿瘤患者凝血功能异常及伴发血管性疾病的临床分析[J]. 河北医药, 2016, 38(11): 1617-1620. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ201611005.htm

    WANG X P, CHENG J F, ZHENG Q Q. Analysis for the coagulation disorder and complicated vascular diseases in patients with JAK2V617F mutation-positive myeloproliferative neoplasms[J]. Hebei Medical Journal, 2016, 38(11): 1617-1620. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ201611005.htm
    [4]
    MURATA M, SUZUKI R, NISHIDA T, et al. Allogeneic hematopoietic stem cell transplantation for post-essential thrombocythemia and post-polycythemia vera myelofibrosis[J]. Intern Med, 2020, 59(16): 1947-1956. doi: 10.2169/internalmedicine.4375-19
    [5]
    HONG J, LEE J H, BYUN J M, et al. Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms[J]. Blood Adv, 2019, 3(22): 3700-3708. doi: 10.1182/bloodadvances.2019000655
    [6]
    GALVEZ C, STEIN B L. Thrombocytosis and thrombosis: Is there really a correlation?[J]. Curr Hematol Malig Rep, 2020, 15(4): 261-267. doi: 10.1007/s11899-020-00588-z
    [7]
    PRAJS I, KULICZKOWSKI K. Predictive factors of thrombosis for patients with essential thrombocythaemia: A single center study[J]. Adv Clin Exp Med, 2017, 26(1): 115-121. doi: 10.17219/acem/68578
    [8]
    JUTZI J S, MULLALLY A. Remodeling the bone marrow microenvironment-a proposal for targeting pro-inflammatory contributors in MPN[J]. Front Immunol, 2020, 11(2): 1-8.
    [9]
    杨旭, 孙慧, 邓丽, 等. 原发性血小板增多症合并心肌梗死10例[J]. 中国循环杂志, 2016, 31(2): 119-121. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH201602005.htm

    YANG X, SUN H, DENG L, et al. Analysis of essential thrombocythemia combining myocardial infarction in 10 patients[J]. Chinese Circulation Journal, 2016, 31(2): 119-121. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH201602005.htm
    [10]
    KHAHESHI I, MEMARYAN M, TAHERKHANI M, et al. Acute ST-segment elevation myocardial infarction as the first manifestation of essential thrombocytosis successfully treated with thrombectomy alone[J]. Cardiovasc Interv Ther, 2016, 31(4): 275-278. doi: 10.1007/s12928-015-0347-z
    [11]
    中华医学会血液学分会白血病淋巴瘤学组. 原发性血小板增多症诊断与治疗中国专家共识(2016年版)[J]. 中华血液学杂志, 2016, 37(10): 833-836. doi: 10.3760/cma.j.issn.0253-2727.2016.10.001

    Leukemia and Lymphoma Group, Chinese Society of He. Chinese expert consensus on the diagnosis and treatment of essential thrombcythaemia (2016)[J]. Chinese Journal of Hematology, 2016, 37(10): 833-836. doi: 10.3760/cma.j.issn.0253-2727.2016.10.001
    [12]
    TEFFERI A, BARBUI T. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management[J]. Am J Hematol, 2019, 94(1): 133-143. doi: 10.1002/ajh.25303
    [13]
    江燕, 杨思进, 白雪, 等. 原发性血小板增多症导致急性心肌梗死1例治疗体会[J]. 临床心血管杂志, 2016, 32(1): 105-107. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB201601029.htm

    JIANG Y, YANG S J, BAI X, et al. Medical treatment experience of acute myocardial infarction resulted from primary thrombocytosis[J]. Journal of Clinical Cardiology, 2016, 32(1): 105-107. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB201601029.htm
    [14]
    ABUTINEH M, YASSIN M A. Extreme levels of platelet count in essential thrombocythemia: Management and outcome, report of two cases[J]. Case Rep Oncol, 2020, 13(2): 606-610. doi: 10.1159/000507363
    [15]
    FRANCHINI M, MANNUCCI P M. Acquired von Willebrand syndrome: Focused for hematologists[J]. Haematologica, 2020, 105(8): 2032-2037.
    [16]
    ROTTENSTREICH A, KLEINSTERN G, KRICHEVSKY S, et al. Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera[J]. Eur J Intern Med, 2017, 41(11): 49-54.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)

    Article Metrics

    Article views (122) PDF downloads(10) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return